| Date Filed | Type | Description |
| 07/05/2023 |
4
| Oltmans Curtis Gale (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 100,000 options to buy
@ $1.14, valued at
$114k
|
|
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2022 |
4
| Oltmans Curtis Gale (SVP, General Counsel) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Granted 60,000 options to buy
@ $12.69, valued at
$761.4k
|
|
| 01/07/2022 |
5
| Oltmans Curtis Gale (SVP, General Counsel) has filed a Form 5 on Fulcrum Therapeutics, Inc. |
| 12/21/2021 |
4
| Oltmans Curtis Gale (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 49,020 shares
@ $0 |
|
| 12/21/2021 |
3
| Oltmans Curtis Gale (Director) has filed a Form 3 on AVENUE THERAPEUTICS, INC. |
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| Oltmans Curtis Gale (SVP, General Counsel) has filed a Form 4 on Fulcrum Therapeutics, Inc.|
Txns:
| Granted 153,600 options to buy
@ $11.82, valued at
$1.8M
|
|
| 12/07/2020 |
3
| Oltmans Curtis Gale (SVP, General Counsel) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 02/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2019 |
4
| Oltmans Curtis Gale (General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 1,251 shares
@ $18, valued at
$22.5k
Exercised 1,251 options to buy
@ $8.94, valued at
$11.2k
|
|
| 01/17/2019 |
4
| Oltmans Curtis Gale (General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 19,720 shares
@ $18.0598, valued at
$356.1k
Exercised 19,720 options to buy
@ $8.94, valued at
$176.3k
|
|
| 12/18/2018 |
4
| Oltmans Curtis Gale (General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 3,079 shares
@ $15.97, valued at
$49.2k
Granted 19,375 restricted stock units
@ $0
Granted 116,250 options to buy
@ $15.97, valued at
$1.9M
Exercised 7,000 restricted stock units
@ $0 |
|
| 08/17/2018 |
4
| Oltmans Curtis Gale (General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Granted 450,000 options to buy
@ $8.94, valued at
$4M
|
|
| 08/17/2018 |
3/A
| Oltmans Curtis Gale (General Counsel) has filed a Form 3/A on ARRAY BIOPHARMA INC |
| 12/19/2017 |
4
| Oltmans Curtis Gale (General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Granted 28,000 restricted stock units
@ $0
Granted 168,000 options to buy
@ $10.92, valued at
$1.8M
|
|
| 08/17/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |